SEVEN STONES – Movers and Thinkers Our team brings together science, marketing and creativity to produce evidence-based solutions • helping support medical treatment in optimising the experience and outcomes for patients and physicians • helping support the sustainability of healthcare provision
- Agency description
A creative healthcare agency of movers and thinkers
Our team brings together science, marketing and creativity to produce evidence-based solutions * helping support medical treatment in optimising the experience and outcomes for patients and physicians * helping support the sustainability of healthcare provision.
What makes us us
We’re scientists and storytellers, artists and athletes.
We are a fiercely proud collective of specialists from a broad range of backgrounds. Bringing together and sharing the experience of disparate disciplines is what helps us shake things up and generate some truly different ideas.
A perfect storm of movers and thinkers.
What we do
We accelerate the change you want to make.
We take on board what you want to say and help translate it into something your customers want, or need, to hear.
Our strategy and positioning work lay the foundation for why it matters. Our creative work helps get the message heard above everything else competing for your audience’s attention.
We don’t believe an idea should depend on a particular type of media. It should be able to live as an app, a tweet, a billboard... in your head.
We take pains over copy, because words become stories which engage our hearts and our heads. And we take as much care over design because it multiplies impact, inviting content to be read.
Who we do it for
We talk (and love) science.
We preach (and practise) exercise.
We have over 25 years’ experience working with landmark brands in healthcare. With expertise in consumer marketing and elite sports coaching, our portfolio also extends to fitness and wearable tech.
While the healthcare arena is naturally evidence-based, the lifestyle sector tends to be behaviourally led. We think there’s a lot to be said for combining both approaches.
Why we do it for ourselves
Charles Darwin, William Wordsworth, Albert Einstein, Pyotr Tchaikovsky, Friedrich Nietzsche, Charles Dickens, Nelson Mandela, Immanuel Kant ...
Forget for a moment that physical inactivity is one of the most important public health problems we face in the 21st century and consider this. Some of the world’s greatest thinkers have used regular movement to enrich their creativity.
When we engage in pursuits that require physical exertion but little thought or concentration, our attention is free to wander. It’s called transient hypofrontality. And it’s precisely the kind of mental state in which ideas mingle more freely and unusual and unexpected thoughts arise.
Movers and thinkers? It’s a no-brainer.
- Key contact
- Chloe Cooper
- Operations Director
- (+)44 (0)207 851 7500
- 2019 Agency Data
- This information was supplied or confirmed by Seven Stones. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
Subscribe to our email news alerts
- Examining this year’s industry performance...
- Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
- Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
- Key success factor (KSF)
- Genital herpes vaccine candidate heads for human studies
- Sangamo steps up BioMarin chase with haemophilia gene therapy data
- Sanofi’s new CEO cuts first deal, adding Synthorx for $2.5bn
- Bluebird bio’s sickle cell gene therapy shows early-study benefit
- J&J and Bristol-Myers Squibb/Bluebird bio reveal rival CAR-T data
- New faces at JPA Health Communications, GCI Health and HRW
- PharmaLex announces joint venture with Vintura
- AZ, Daiichi Sankyo strengthen case for HER2 candidate
- Biologic patent exclusivity scrapped in new US trade deal
- UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe
- Intec battered as Novartis ducks out of Accordion collaboration